"Private clinical trial institute striving to bring the latest therapeutics advances to the patients."

During the past decade, El Paso Medical Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "El Paso Medical Research Institute" are "Diabetes Mellitus, Type 1" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "El Paso Medical Research Institute" in a lesser frequency.

Most popular intervention types in "El Paso Medical Research Institute" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS-986165" (1 trials), "Gan & Lee Insulin Lispro Injection" (1 trials), "Humalog" (1 trials), "Mycophenolate Mofetil" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "El Paso Medical Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "El Paso Medical Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in El Paso Medical Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in El Paso Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".